cancer treatment – Medxy AI

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma

By MedXY 05/08/2026

A cohort study demonstrates that reduced-dose 60-Gy chemoradiotherapy effectively maintains locoregional control in HPV-positive oropharyngeal cancer patients while minimizing treatment toxicity, with 5-year survival rates exceeding 92%.

Hematology-Oncology news Oncology

RNA Cancer Vaccines: Revolutionary Advances Bringing Hope for 2029 Clinical Use

By MedXY 11/14/2025

RNA cancer vaccines are emerging as powerful tools against hard-to-treat cancers, with breakthroughs in melanoma, pancreatic, and brain cancers showing promise for widespread clinical adoption by 2029.

Hematology-Oncology

From Discovery to Breakthroughs: How Multiple Myeloma Survival Has Doubled in 20 Years

By MedXY 10/24/2025

Over the past two decades, advances in therapy have doubled the median survival of multiple myeloma patients, transforming this once devastating cancer into a more manageable disease through targeted drugs and immune therapies.

Clinical Updates news Oncology Specialties

Cancer Treatment and Genetic Predisposition Drive Subsequent Neoplasm Risk in Childhood Cancer Survivors

By MedXY 08/03/2025

A comprehensive analysis reveals that radiotherapy, chemotherapy, and genetic factors substantially contribute to subsequent neoplasms in long-term childhood cancer survivors, while lifestyle factors play a minimal role.

Medical News Oncology

AI-Designed Proteins Revolutionize Personalized Cancer Treatment

By MedXY 07/25/2025

AI-powered protein design offers a fast, personalized approach to cancer treatment, enhancing immune response and minimizing side effects.